EE03101B1 - Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline kompositsioon - Google Patents
Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline kompositsioonInfo
- Publication number
- EE03101B1 EE03101B1 EE9400181A EE9400181A EE03101B1 EE 03101 B1 EE03101 B1 EE 03101B1 EE 9400181 A EE9400181 A EE 9400181A EE 9400181 A EE9400181 A EE 9400181A EE 03101 B1 EE03101 B1 EE 03101B1
- Authority
- EE
- Estonia
- Prior art keywords
- preparation
- pharmaceutical composition
- peptide compounds
- peptide
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929211668A GB9211668D0 (en) | 1992-06-02 | 1992-06-02 | Peptide compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE03101B1 true EE03101B1 (et) | 1998-06-15 |
Family
ID=10716403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EE9400181A EE03101B1 (et) | 1992-06-02 | 1994-11-16 | Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline kompositsioon |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5629293A (lv) |
| EP (1) | EP0643725A1 (lv) |
| JP (1) | JPH08501067A (lv) |
| CN (1) | CN1085912A (lv) |
| AU (1) | AU4340493A (lv) |
| EE (1) | EE03101B1 (lv) |
| GB (1) | GB9211668D0 (lv) |
| LT (1) | LT3615B (lv) |
| LV (1) | LV10287B (lv) |
| NO (1) | NO944670L (lv) |
| TW (1) | TW329427B (lv) |
| WO (1) | WO1993024524A1 (lv) |
| ZA (1) | ZA933866B (lv) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9425730D0 (en) * | 1994-12-20 | 1995-02-22 | Nycomed Pharma As | Compounds |
| US6908899B2 (en) * | 2001-08-17 | 2005-06-21 | U.S. Dept. Of Veterans Affairs | Pro-inflammatory fibrinopeptide |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3778426A (en) * | 1970-12-16 | 1973-12-11 | Research Corp | Therapeutically useful polypeptides |
| US4171299A (en) * | 1975-04-04 | 1979-10-16 | The Regents Of The University Of California | Polypeptide agents for blocking the human allergic response |
| ZA838780B (en) | 1982-11-26 | 1985-01-30 | Nyegaard & Co As | Peptide compounds |
| US4816449A (en) * | 1984-08-09 | 1989-03-28 | Immunetech Pharmaceuticals | Immunotherapeutic anti-inflammatory peptide agents |
| US4579840A (en) * | 1983-08-12 | 1986-04-01 | Immunetech Pharmaceuticals | Method of blocking immune complex binding to immunoglobulin Fc receptors |
| FR2567524B1 (fr) * | 1984-07-10 | 1987-11-27 | Sanofi Sa | Procede de synthese de la somatocrinine en phase liquide et peptides intermediaires |
| ZA846192B (en) * | 1984-08-09 | 1986-03-26 | Merck Patent Gmbh | Immunotherapeutic polypeptide agents |
| GB8626539D0 (en) | 1986-11-06 | 1986-12-10 | Nycomed As | Peptide compounds |
| GB8630721D0 (en) * | 1986-12-23 | 1987-02-04 | Unilever Plc | Cosmetic compositions |
| GB8821785D0 (en) * | 1988-09-16 | 1988-10-19 | Nycomed As | Peptide compounds |
| GB8905606D0 (en) * | 1989-03-11 | 1989-04-26 | Scras | Peptides |
| ZW11290A1 (en) | 1989-07-14 | 1990-10-31 | Smithkline Beecham Corp | Hemoregulatory peptides |
| HU206372B (en) * | 1990-09-03 | 1992-10-28 | Richter Gedeon Vegyeszet | Process for producing new oligopeptides which selectively inhibit proliferation of haemopoietic cells and pharmaceutical compositions comprising same |
| TW222280B (lv) * | 1991-11-26 | 1994-04-11 | Smithkline Beecham Corp |
-
1992
- 1992-06-02 GB GB929211668A patent/GB9211668D0/en active Pending
-
1993
- 1993-06-02 CN CN93108406A patent/CN1085912A/zh active Pending
- 1993-06-02 WO PCT/GB1993/001172 patent/WO1993024524A1/en not_active Application Discontinuation
- 1993-06-02 JP JP6500363A patent/JPH08501067A/ja active Pending
- 1993-06-02 AU AU43404/93A patent/AU4340493A/en not_active Abandoned
- 1993-06-02 LV LVP-93-458A patent/LV10287B/xx unknown
- 1993-06-02 EP EP93913277A patent/EP0643725A1/en not_active Withdrawn
- 1993-06-02 US US08/343,602 patent/US5629293A/en not_active Expired - Fee Related
- 1993-06-02 ZA ZA933866A patent/ZA933866B/xx unknown
- 1993-06-02 LT LTIP608A patent/LT3615B/lt not_active IP Right Cessation
- 1993-07-20 TW TW082105780A patent/TW329427B/zh active
-
1994
- 1994-11-16 EE EE9400181A patent/EE03101B1/xx unknown
- 1994-12-02 NO NO944670A patent/NO944670L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB9211668D0 (en) | 1992-07-15 |
| NO944670L (no) | 1995-01-19 |
| WO1993024524A1 (en) | 1993-12-09 |
| TW329427B (en) | 1998-04-11 |
| LTIP608A (en) | 1995-01-31 |
| EP0643725A1 (en) | 1995-03-22 |
| LV10287B (en) | 1995-04-20 |
| LV10287A (lv) | 1994-10-20 |
| CN1085912A (zh) | 1994-04-27 |
| ZA933866B (en) | 1994-06-14 |
| NO944670D0 (no) | 1994-12-02 |
| US5629293A (en) | 1997-05-13 |
| LT3615B (en) | 1995-12-27 |
| JPH08501067A (ja) | 1996-02-06 |
| AU4340493A (en) | 1993-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE03177B1 (et) | Heterobitsüklilised ühendid, nende saamismeetod ja nimetatud ühendeid sisaldavad farmatseutilised kompositsioonid | |
| BR1100824A (pt) | Composto e composição farmacêutica | |
| EE9700145A (et) | Tsükloalkaanpüridiinid, nende valmistamismeetod, kasutamine ravimite tootmiseks ja nimetatud ühendeid sisaldavad ravimid | |
| EE9500064A (et) | Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid | |
| EE9700061A (et) | Farmatseutiline aerosoolpreparaat ja selle valmistamismeetod | |
| BR9602933A (pt) | Compostos processos para preparação de composto e de composição farmacêutica e composto | |
| IT1235532B (it) | Composti carbossiammidici, procedimenti per la preparazione dei medesimi e composizione farmaceutica contenente i medesimi | |
| FI943571A0 (fi) | 1-bentseenisulfonyyli-1,3-dihydro-2H-bentsimidatsol-2-onijohdannaisia, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset | |
| EE9800234A (et) | Ravimeetod ja farmatseutiline kompositsioon | |
| EE04681B1 (et) | 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon | |
| FI951789A (fi) | Uusia taksaanijohdannaisia, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset | |
| FI942932A (fi) | Farmaseuttinen koostumus ja menetelmä sen valmistamiseksi | |
| IT8922164A0 (it) | Composizione farmaceutica e procedimento per la sua preparazione | |
| FI961938A0 (fi) | Uudet taksoidit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet | |
| FI960316A (fi) | Oksatiolaanit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
| FI955123A (fi) | Kolestyramiinia sisältävä koostumus ja menetelmä tämän valmistamiseksi | |
| EE9400182A (et) | Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline segu | |
| NO305750B1 (no) | Substituerte benzensulfonylureaer og deres anvendelse for fremstilling av farmas°ytiske preparater samt farmas°ytiske preparater inneholdende forbindelsene | |
| BR9610851A (pt) | Composto processo de preparação de composto medicamento composição farmacêuticas e utilização do composto | |
| EE03101B1 (et) | Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline kompositsioon | |
| FI960688A (fi) | Substituoituja bentseenisulfonyyliureoita ja -tioureoita, menetelmä niiden valmistamiseksi ja näihin yhdisteisiin perustuvien farmaseuttisten valmisteiden käyttö sekä niitä sisältäviä lääkkeitä | |
| EE9500029A (et) | Farmatseutiline pihustatav kompositsioon ja selle saamise meetod | |
| FI952859A0 (fi) | Antasidikoostumus ja sen valmistusmenetelmä | |
| FI934387A0 (fi) | 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner | |
| FI940717A (fi) | Streptogramiinien puhdistetut muodot, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet |